The Corporate Governance Report presents the structure, rules and processes that form the basis of Lonza’s corporate governance. The Report follows the structure of the SIX Swiss Exchange’s Directive on Information relating to Corporate Governance. The principles and rules of Lonza’s corporate governance are laid down in the Lonza Articles of Association and in the Regulations Governing Internal Organization and Board Committees, including their Charters. In the implementation of its corporate governance, Lonza follows the Swiss Code of Best Practice for Corporate Governance issued by the Swiss Business Federation economiesuisse.
Operational Group Structure
1 Fridtjof Helemann was Chief Human Resource Officer (CHRO) from 2016 until March 2019
2 Mark Funk was CEO from March 2019 until 12 November 2019
3 Richard Ridinger was CEO from May 2012 until February 2019
Leadership
Left to right Olivier Verscheure, BoD; Werner Bauer, BoD; Stefan Stoffel, COO LPBN; Margot Scheltema, BoD; Christoph Mäder, BoD and LID; Angelica Kohlmann BoD; Sven Abend, COO LSI; Albert M. Baehny, Chairman BoD and CEO a.i.; Jürgen Steinemann, BoD; Barbara Richmond, BoD; Patrick Aebischer, Vice-Chairman BoD; Rodolfo J. Savitzky, CFO; Andreas Bohrer, Company Secretary
CVs Board of Directors
Albert M. Baehny
Chairman and CEO a.i.
Nationality: Swiss | Year of birth: 1952
Chairman of the Board of Directors (since 2018), Chief Executive Officer (CEO) ad interim (since November 2019)
On 12 November 2019, Albert M. Baehny took on the responsibilities as CEO ad interim until a permanent successor is found. He is a member of the Board of Directors of Lonza Group Ltd (since April 2017).
Albert M. Baehny holds a degree in biology from the University of Fribourg (CH).
Current Activities and Functions
Public Company Boards:
- Member of the Board of Directors of Investis Group Holding SA (since 2016)
- Chairman of the Board of Directors of Geberit AG (since 2011)
Former Activities and Functions
- CEO of Geberit Group (2005–2014)
- Head of Group Division Marketing and Sales Europe for Geberit Group (2003–2004)
- Senior Vice-President at Wacker Chemie AG (2001–2002)
- Various Marketing, Sales, Strategic Planning and Global Management Positions with:
- Vantico (2000–2001)
- Ciba-Geigy / Ciba Specialty Chemicals (1994–2000)
- Dow Chemicals Europe (1981–1993)(1981–1993)
- Serono-Hypolab (1979–1981)
Patrick Aebischer
Vice-Chairman
Nationality: Swiss | Year of birth: 1954
Vice-Chairman of the Board of Directors of Lonza Group Ltd (since April 2014), Independent member of the Board of Directors of Lonza Group Ltd (since March 2008)
Patrick Aebischer holds a doctorate in medicine from the University of Geneva (CH). He has received numerous honors, including the Robert Bing Prize of the Swiss Academy of Medicine and the Pfizer Foundation Prize for Clinical Neurosciences.
Current Activities and Functions
Public Company Boards:
- Member of the Board of Directors of Logitech SA (since 2016)
- Member of the Board of Directors of Nestlé SA (since 2015)
Further Appointments:
- Chairman of the Board of Directors of Arctos SA (since 2019)
- Senior Partner of NanoDimension Management Limited (since 2017)
- Scientific technical committee member of the Italian Institute of Technology (since 2015)
- Chairman of the Novartis Venture Fund (since 2014)
- Member of the Singapore Biomedical Sciences International Advisory Council (since 2013)
- Chairman of the Board of Amazentis SA (since 2007)
- Professor of Neurosciences, Swiss Federal Institute of Technology Lausanne (EPFL) (since 2000)
Former Activities and Functions
- Senate member of the Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) (2016–2019)
- Representative of the EPFL on the boards of various Swiss foundations
- President of the Swiss Federal Institute of Technology of Lausanne (EPFL) (2000–2016)
- Member of the Foundation Board of the World Economic Forum (2013–2016)
Werner Bauer
Member
Nationality: Swiss | Year of birth: 1950
Independent member of the Board of Directors of Lonza Group Ltd (since April 2013).
Werner Bauer holds a diploma and PhD in chemical engineering from the University of Erlangen-Nürnberg (DE). He has received several scientific honors, among others the BioAlps Award 2011 and Honorary Senator from the Technical University of Munich (DE).
Current Activities and Functions
Public Company Boards:
- Member of the Board of Directors of SIG Combibloc Group AG (since 2018)
- Vice-Chairman of the Board of Directors of Givaudan SA (since 2014)
Further Appointments:
- Member of the Board of Directors of the Urs Bühler Innovation Fund (since 2019)
- Vice-Chairman of the Supervisory Board of Bertelsmann SE & Co. KGaA (since 2012)
- SChairman of the Board of Trustees of the Bertelsmann Foundation (since 2003)
Former Activities and Functions
- Member of the Supervisory Board of GEA Group AG (2011–2018)
- Chairman of the Supervisory Board of Nestlé Deutschland AG (2007–2017)
- Executive Vice-President of Nestlé SA, Head of Innovation, Technology, Research and Development (2007–2013)
- Executive Vice-President of Nestlé SA, Head of Technical, Production, Environment, Research & Development (2002–2007)
- Various managerial positions of increasing responsibility at Nestlé (1990–2002)
- Chairman of the Board of Directors of Galderma Pharma SA (2011–2014)
- Member of the Board of Directors of L’OREAL, France (2005–2012)
- Member of the Board of Directors of Alcon Inc., Switzerland (2002–2010)
- Director of the Fraunhofer Institute for Food Technology & Packaging and Professor in Bioprocess Technology at Technical University Munich (DE) (1985–1990)
- Professor of Chemical Engineering at the Technical University of Hamburg (DE) (1980–1985)
Angelica Kohlmann
Member
Nationality: German-Brazilian | Year of birth: 1960
Independent member of the Board of Directors of Lonza Group Ltd (since May 2018).
Angelica Kohlmann holds a MD and doctorate in medicine from Hamburg University (DE).
Current Activities and Functions
- Member International Advisory Board IE University and Business School, Madrid (since 2017)
- Chairperson of the Board of Directors of Bloom Diagnostics AG (since 2014)
- International investor in biotech and tech, based in Switzerland (since 2014)
- Chairperson of the Board of Directors of Kohlmann & Co AG (since 2013)
- Member of the Board of Directors of Teralytics AG (since 2013)
- Chairperson of the Advisory Board Peter Drucker Society Europe / Global Peter Drucker Forum, Vienna (since 2009)
Former Activities and Functions
- Member of the Advisory Board of UBS Unique (2017–2018)
- Director of the Trinnacle Fund Ltd (2016–2017)
- Founder & CEO of Ifitech GmbH, based in Germany (2010–2017)
- International investor in biotech and tech, based in Germany (2000–2013)
- International consultant for strategy, management, investments and restructuring (1992–1999)
- Head of global restructuring Behringwerke AG, Germany (1990–1992)
- Member of the Board Staff Hoechst AG, Germany (1988–1990)
- International Marketing Group Leader at Behringwerke AG (1986–1988)
- MD Anderson Cancer Center, Houston and Memorial Sloan Kettering Cancer Center, New York, USA – various cancer research functions
Christoph Mäder
Member
Nationality: Swiss | Year of birth: 1959
Independent member of the Board of Directors of Lonza Group Ltd (since April 2016). On 12 November 2019 Christoph Mäder has been appointed Lead Independent Director by the Board.
Christoph Mäder holds a Master’s degree in law from the University of Basel (CH) and is admitted to the Swiss Bar.
Current Activities and Functions
Public Company Boards:
- Member of the Board of Directors EMS Chemie Holding AG (since 2018)
- Member of the Board of Directors Baloise Holding AG (since 2019)
Further Appointments:
- Member of the Board of Directors Assivalor AG (since 2019)
- Member of the Advisory Board of Accenture Switzerland (since 2019)
- Partner at the law firm Becker-Gurini-Hanhart-Vogt (since 2019)
- Member of the Council of Schweizer Jugend forscht (since 2018)
- Member of the Advisory Board of Vereinigung Schweizerischer Unternehmen in Deutschland (since 2016)
- Member of the Advisory Board of Loeba GmbH (since 2014)
Former Activities and Functions
- Member of the Group Executive Committee of Syngenta (2000–2018)
- Member of the Board Committee of economiesuisse (2008–2019)
- Vice-Chairman of economiesuisse (2011–2017)
- Member of the Executive Board of the Business and Industry Advisory Committee (BIAC) for the Organization for Economic Co-operation and Development (OECD) (2012–2016)
- Member of the Board of scienceindustries (2006–2018)
- Member of the Board of the Basel Chamber of Commerce (2002–2018)
- Head of Legal & Public Affairs for Novartis Crop Protection AG (1999–2000)
- Senior Corporate Counsel for Novartis International AG (1992–1998)
Barbara Richmond
Member
Nationality: British | Year of birth: 1960
Independent member of the Board of Directors of Lonza Group Ltd (since April 2014).
Barbara Richmond holds a first-class degree in management science from the University of Manchester Institute of Science and Technology in England. Barbara Richmond has substantial knowledge as a financial expert, demonstrated by her roles as CFO for various companies. She is a Fellow of the Institute of Chartered Accountants in England and Wales.
Current Activities and Functions
Public Company Boards:
- Group CFO of Redrow plc (since 2010)
Former Activities and Functions
- Group CFO of Inchcape plc (2006–2009)
- Non-Executive Director and Audit Committee Chair of Scarborough Building Society until its merger with The Skipton Building Society (2005–2009)
- Non-Executive Director, Senior Independent Director and Audit Committee Chair of Carclo Group plc (2000–2006)
- Group CFO of Croda International plc (1997–2006) with dual role as Group CFO and President of Active Ingredients and Industrial Chemicals from 2002 to 2006
- Group CFO of Whessoe plc in 1993 (1993–1997)
- Various financial roles in Alstom Group SA (1987–1992)
- Auditor and management consultant for Arthur Andersen (1981–1984)
Margot Scheltema
Member
Nationality: Dutch | Year of birth: 1954
Independent member of the Board of Directors of Lonza Group Ltd (since April 2012).
Margot Scheltema holds a doctorate in international law from the University of Amsterdam and a Master of International Affairs (MIA) from Columbia University in New York, NY (USA). Margot Scheltema has substantial knowledge as a finance, corporate governance and risk management expert, demonstrated by her operative roles in finance and management and supervisory roles in the financial sector (bank, central bank, insurance and pension funds).
Current Activities and Functions
Public Company Boards:
- NEDAP (NE Director) NV (since 2018)
Further Appointments:
- Vice-chair of the Supervisory Board of the Dutch Central Bank (since 2015) (financial institution)
- Chair of the Monitoring Committee of the Dutch Pension Fund Code (since 2014)
- Member of the Central Plan Committee Dutch Planning Bureau (since 2014)
- Council to the Enterprise Chamber of the Amsterdam Court of Appeal (since 2013)
- Member of the Supervisory Board of Warmtebedrijf Rotterdam (since 2011)
- Member of the Supervisory Board of TNT Nederland BV (since 2011)
Former Activities and Functions
- Non-executive Director at Schiphol Group (2010–2018)
- Vice-Chair of the Supervisory Board of Triodos Bank (2006–2015)
- Member of the Supervisory Board of ASR NV (2008–2015)
- External Member of the Audit Committee of the Dutch pension fund ABP (2010 to July 2014) (financial institution)
- Member of the Supervisory Board of the Rijksmuseum (2007–2015)
- Member of the AFM External Reporting Committee (2006–2012)
- Finance Director of Shell Nederland BV (2004–2008)
- Various managerial positions in finance within the Shell Group (1985–2004) including Senior M&A Adviser for Shell Oil Products Latin America
Jürgen Steinemann
Member
Nationality: German | Year of birth: 1958
Independent member of the Board of Directors of Lonza Group Ltd (since April 2014).
Jürgen Steinemann holds a degree in economics and business management from the European Business School in Wiesbaden (DE), London (UK) and Paris (FR).
Current Activities and Functions
Public Company Boards:
- Chairman of the Supervisory Board of Metro AG (since 2015)
Further Appointments:
- Managing Director of JBS Holding GmbH (since 2017)
- Chairman of the Supervisory Board of Bankiva B.V. (since 2017)
- Member of the Senior Advisory Board of Tower Brook Capital Partners LP (since 2017)
- Chairman of the Supervisory Board of Big Dutchman AG (since 2019)
Former Activities and Functions
- Member of the Board of Directors of Barry Callebaut AG (2015–2019)
- Member of the Supervisory Board of Big Dutchman AG (2015–2019)
- Chief Executive Officer of Barry Callebaut Ltd (2009–2015)
- Member of the Board of the Swiss-American Chamber of Commerce (2011–2015)
- Member of the Executive Board and Chief Operating Officer of Nutreco (2001–2009)
- Chief Executive Officer of Loders Croklaan (1999–2001)
- Various senior positions in business-to-business marketing and sales with the former Eridania Béghin-Say Group, ultimately in the “Corporate Plan et Stratégie” unit at the head office in Paris (1990–1998)
Olivier Verscheure
Member
Nationality: Belgian | Year of birth: 1972
Independent member of the Board of Directors of Lonza Group Ltd (since May 2018).
Olivier Verscheure holds a PhD in computer science from the Swiss Federal Institute of Technology, Lausanne (CH) (EPFL, July 1999).
Current Activities and Functions
- Expert in the Strategy Working Group on Data, Computing and Digital Research lnfrastructures in the State Secretariat for Education, Research and Innovation (SERI) (since 2019)
- Member of the Foundation Council of SWITCH (since 2019)
- Founder and Executive Director of the Swiss Data Science Center, a joint venture between EPFL and ETH Zürich (since 2016)
- Member of the Executive Committee of Personalized Health and Related Technologies (PHRT), an ETH Domain Strategic Focus Area (since 2017)
- Co-academic Director, Certificate of Advanced Studies (CAS), Data Science and Management, HEC Lausanne and EPFL (since 2018)
Former Activities and Functions
- Lab Program Director and Senior Research Manager at IBM Research Ireland (2010–2016)
- Research Manager and Senior Member of the Research Staff at the IBM T.J. Watson Research Center (1999–2010)
CVs Executive Committee
Members of the Executive Committee as of 31 Dec 2019
Albert M. Baehny
Chairman and CEO a.i.
Nationality: Swiss | Year of birth: 1952
Chairman of the Board of Directors (since 2018), Chief Executive Officer (CEO) ad interim (since November 2019)
On 12 November 2019, Albert M. Baehny took on the responsibilities as CEO ad interim until a permanent successor is found. He is a member of the Board of Directors of Lonza Group Ltd (since April 2017).
Albert M. Baehny holds a degree in biology from the University of Fribourg (CH).
Current Activities and Functions
Public Company Boards:
- Member of the Board of Directors of Investis Group Holding SA (since 2016)
- Chairman of the Board of Directors of Geberit AG (since 2011)
Former Activities and Functions
- CEO of Geberit Group (2005–2014)
- Head of Group Division Marketing and Sales Europe for Geberit Group (2003–2004)
- Senior Vice-President at Wacker Chemie AG (2001–2002)
- Various Marketing, Sales, Strategic Planning and Global Management Positions with:
- Vantico (2000–2001)
- Ciba-Geigy / Ciba Specialty Chemicals (1994–2000)
- Dow Chemicals Europe (1981–1993)(1981–1993)
- Serono-Hypolab (1979–1981)
Rodolfo J. Savitzky
CFO
Nationality: Swiss | Year of birth: 1962
Chief Financial Officer (CFO) and Member of the Executive Committee (since October 2016).
Rodolfo J. Savitzky holds a degree in industrial and systems engineering from the Tecnológico de Monterrey (MX) and an MBA in finance and economics from the University of Chicago (USA).
Former Activities and Functions
- Vice-President Controller, Lonza Pharma & Biotech (2015–2016)
- Division CFO, Novartis Animal Health (2011–2015)
- Head of Finance Animal Health, Novartis Consumer Health (2006–2011)
- Head of Strategy Planning and Analysis, Novartis Pharmaceuticals (2004–2005)
- Head of Business Planning and Analysis, Novartis Pharmaceuticals (2003–2004)
- Head of Finance Ophthalmics, Novartis Pharmaceuticals (2002–2003)
- Various positions at Procter & Gamble (1990–2001)
Stefan Stoffel
COO LPBN
Nationality: Swiss | Year of birth: 1966
Chief Operating Officer (COO) Pharma & Biotech Segment (since March 2019) and Member of the Executive Committee (since March 2019).
Stefan Stoffel holds a Bachelor’s degree in engineering from Lucerne University of Applied Sciences and Arts.
Former Activities and Functions
- Head of Lonza Pharma & Biotech Strategic Growth Investments and IbexTM Solutions (2016–2019)
- Head of Lonza Pharma & Biotech Operations (2013–2016)
- General Manager of Lonza Chemical Operations Business Unit (2010–2013)
- Head of Lonza’s Small Molecules Exclusive Synthesis Business Unit (2009–2010)
- Head of Operations for Lonza’s Small Molecules Exclusive Synthesis Business Unit (2007–2009)
- Various positions at Lonza in Engineering & Maintenance, Technical Management, Production and Operations Management for Lonza AG and Lonza Inc. (1991–2007)
Sven Abend
COO LSI
Nationality: German | Year of birth: 1968
Chief Operating Officer (COO) Specialty Ingredients Segment (since January 2016) and Member of the Executive Committee (since July 2014).
Sven Abend holds a PhD in chemistry from the Christian-Albrechts-Universität in Kiel and a post-doctorate from the Department of Physics & Astronomy at the University of New York in Stony Brook, NY (USA).
Former Activities and Functions
- CEO of Kolb Ltd in Hedingen (CH) (2012–2014)
- Business Manager for Kolb’s divisions focusing on specialty surfactants and custom manufacturing (2010–2012)
- Several senior positions in Global Product Management and ultimately as Director of Corporate Key Account Management at Cognis GmbH in Germany (2003–2010)
- Project Scientist for the R&D Home & Personal Care business at Unilever in the UK (2000–2003)
Former Members of the Executive Committee in 2019
Marc Funk
Nationality: Swiss | Year of birth: 1960
Chief Executive Officer (CEO) (from March 2019 until 12 November 2019) and Member of the Executive Committee (from April 2012).
Marc Funk holds a Master of Law from the University of Geneva (CH) and a Master of Law and Diplomacy from the Fletcher School - Tufts University, MA (USA).
Current Activities and Functions
- Member of the Board of Directors of Swiss Polar Foundation (since 2019)
Former Activities and Functions
- Chief Operating Officer (COO) Pharma & Biotech Segment (2014–2019)
- Group General Counsel and Board Secretary Lonza Group Ltd (2009–2014)
- Associate General Counsel of Merck Serono (formerly Serono) (2004–2008)
- Co-CEO and General Counsel of GeneProt (2000–2004)
Richard Ridinger
Nationality: German | Year of birth: 1958
Chief Executive Officer (CEO) and Member of the Executive Committee (from May 2012 until February 2019).
Richard Ridinger holds a degree in chemical engineering from the University of Karlsruhe (DE).
Current Activities and Functions
- Member of the Board of Directors of Novo Advisory Group (since 2019)
- Member of the Board of Directors of Firmenich International SA (since 2016)
Former Activities and Functions
- Transfer and integration of Cognis GmbH into BASF (2011)
- Member of the Management Board and Executive Vice-President “Care Chemicals” of Cognis GmbH (2006–2010)
- SBU Head of “Cognis Care Chemicals” and member of the Cognis Executive Committee (2002–2006)
- Vice-President of the global “Care Chemicals Specialties” business of Cognis GmbH (2000–2002)
- Director of the global Skin Care Ingredients business at Henkel KGaA / Cognis GmbH (1999–2000)
- Various positions at Henkel KGaA in R&D, Engineering and Production Management (1986–1999)
Fridtjof Helemann
Nationality: German | Year of birth: 1954
Chief Human Resource Officer (CHRO) (since 2016 until March 2019) and Member of the Executive Committee (since February 2017 until March 2019).
Fridtjof Helemann holds a degree in engineering from the University of Siegen (DE) and is a Certified Professional Coach from the Coaches Training Institute in California (USA).
Current Activities and Functions
- Mentor at Merryck & Co (since 2019)
- Chairman of GetUp Coaching GmbH (since 2019)
Former Activities and Functions
- Managing Partner and President of Oxford Leadership (2014–2016)
- Partner and CEO Mercer Inc. Central Europe (2011–2014)
- Vice-President and General Manager Central and Eastern Europe at Right Management (2010–2011)
- Corporate Vice-President HR Henkel AG (2003–2009)
- Various HR consulting roles: Partner Hay Group and MD Kienbaum